1. Home
  2. NWGL vs TENX Comparison

NWGL vs TENX Comparison

Compare NWGL & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • TENX
  • Stock Information
  • Founded
  • NWGL 2008
  • TENX 1967
  • Country
  • NWGL Macau
  • TENX United States
  • Employees
  • NWGL N/A
  • TENX N/A
  • Industry
  • NWGL
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • TENX Health Care
  • Exchange
  • NWGL Nasdaq
  • TENX Nasdaq
  • Market Cap
  • NWGL 22.8M
  • TENX 27.3M
  • IPO Year
  • NWGL 2023
  • TENX N/A
  • Fundamental
  • Price
  • NWGL $1.17
  • TENX $6.96
  • Analyst Decision
  • NWGL
  • TENX Strong Buy
  • Analyst Count
  • NWGL 0
  • TENX 2
  • Target Price
  • NWGL N/A
  • TENX $17.00
  • AVG Volume (30 Days)
  • NWGL 14.9K
  • TENX 72.3K
  • Earning Date
  • NWGL 11-29-2025
  • TENX 11-14-2025
  • Dividend Yield
  • NWGL N/A
  • TENX N/A
  • EPS Growth
  • NWGL N/A
  • TENX N/A
  • EPS
  • NWGL N/A
  • TENX N/A
  • Revenue
  • NWGL $21,539,347.00
  • TENX N/A
  • Revenue This Year
  • NWGL N/A
  • TENX N/A
  • Revenue Next Year
  • NWGL N/A
  • TENX N/A
  • P/E Ratio
  • NWGL N/A
  • TENX N/A
  • Revenue Growth
  • NWGL N/A
  • TENX N/A
  • 52 Week Low
  • NWGL $0.91
  • TENX $4.50
  • 52 Week High
  • NWGL $6.61
  • TENX $8.24
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 36.57
  • TENX 45.76
  • Support Level
  • NWGL $1.30
  • TENX $6.51
  • Resistance Level
  • NWGL $1.48
  • TENX $7.31
  • Average True Range (ATR)
  • NWGL 0.12
  • TENX 0.46
  • MACD
  • NWGL -0.05
  • TENX -0.07
  • Stochastic Oscillator
  • NWGL 3.33
  • TENX 52.06

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: